Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007

Drug and Alcohol Dependence

Volumn 115, Issue 3, 2011, Pages 221-228

  Green, Traci C ^a   Grau, Lauretta E ^b   Carver, H Wayne ^c   Kinzly, Mark ^b   Heimer, Robert ^b  

^a BROWN UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Office of the Chief Medical Examiner   (United States)

Author keywords

Heroin; Mortality; Opioid; Overdose; Prescription opioid

Indexed keywords

ANTIDEPRESSANT AGENT; DIAMORPHINE; FENTANYL; METHADONE; OPIATE; OXYCODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORONER; DRUG CLASSIFICATION; DRUG INTOXICATION; DRUG OVERDOSE; ETHNIC DIFFERENCE; FATALITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SEX DIFFERENCE; SUBURBAN AREA; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; CAUSE OF DEATH; CONNECTICUT; FEMALE; HEROIN; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; OVERDOSE; PRESCRIPTION DRUGS; YOUNG ADULT;

EID: 79955786737     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.11.007     Document Type: Article

References (45)

1. Agresti A. An Introduction to Categorical Data Analysis 2007, John Wiley & Sons, Hoboken, NJ.
2. Brownstein J.S., Green T.C., Cassidy T.A., Butler S.F. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol. Drug Saf. 2010, 19:627-637.
3. Calefati J. Heroin Hits the Suburbs Hard Amid Wave of Drug Abuse by Teens and 20-Somethings. US News and World Report 2008.
4. Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int. J. Drug Policy 2009, 20:277-282.
5. Ciccarone D., Unick G.J., Kraus A. Impact of South American heroin on the US heroin market 1993-2004. Int. J. Drug Policy 2009, 20:392-401.
6. Cohn A. Team 8 Investigates Methadone Prescriptions 2/19/2008.
7. Dasgupta N., Jonsson Funk M., Brownstein J. Comparing unintentional opioid poisoning mortality in metropolitan and non-metropolitan counties, United States, 1999-2003. Geography and Drug Addiction 2008, Springer Publishers (Collaboration between the National Institute on Drug Abuse and the Association of American Geographers). Y. Thomas, T.D. Richardson, I. Cheung (Eds.).
8. Dasgupta N., Mandl K.D., Brownstein J.S. Breaking the news or fueling the epidemic? Temporal association between news media report volume and opioid-related mortality. PLoS ONE 2009, 4:e7758.
9. Dasgupta N., Sanford C., Albert S., Brason F.W. Opioid drug overdoses: a prescription for harm and potential for prevention. Am. J. Lifestyle Med. 2010, 32-37.
10. Doe-Simkins M., Walley A.Y., Epstein A., Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am. J. Public Health 2009, 99:788-791.
11. Fan D.P. News media framing sets public opinion that drugs is the country's most important problem. Subst. Use Misuse 1996, 31:1413-1421.
12. Fox T., Leukhardt B. Small Town, Big-Time Heroin Use 2002, Hartford Courant, Hartford, CT.
13. Frank B. An overview of heroin trends in New York City: past, present and future. Mt. Sinai J. Med. 2000, 67:340-346.
14. Garfield J., Drucker E. Fatal overdose trends in major U.S. cities: 1990-1997. Addict. Res. Theory 2001, 9:425-436.
15. Grau L.E., Dasgupta N., Harvey A.P., Irwin K., Givens A., Kinzly M.L., Heimer R. Illicit use of opioids: is OxyContin a " gateway drug" ?. Am. J. Addict. 2007, 16:166-173.
16. Green T.C., Heimer R., Grau L.E. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 2008, 103:979-989.
17. Grund J.P., Heckathorn D.D., Broadhead R.S., Anthony D.L. In eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10:104-105.
18. Hall A.J., Logan J.E., Toblin R.L., Kaplan J.A., Kraner J.C., Bixler D., Crosby A.E., Paulozzi L.J. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008, 300:2613-2620.
19. Havens J.R., Talbert J.C., Walker R., Leedham C., Leukefeld C.G. Trends in controlled-release oxycodone (OxyContin) prescribing among Medicaid recipients in Kentucky, 1998-2002. J. Rural Health 2006, 22:276-278.
20. Inciardi J.A., Surratt H.L., Cicero T.J., Beard R.A. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med. 2009, 10:537-548.
21. James M. FDA. Maker Warn Doctors on OxyContin 2001, ABCNEwscom.
22. Levy M.S. An exploratory study of OxyContin use among individuals with substance use disorders. J. Psychoactive Drugs 2007, 39:271-276.
23. Manchikanti L., Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008, 11:S63-S88.
24. Maxwell S., Bigg D., Stanczykiewicz K., Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J. Addict. Dis. 2006, 25:89-96.
25. McLafferty S. Placing substance abuse. Geography and Drug Addiction 2008, Springer, New York. Y. Thomas, D. Richardson, I. Cheung (Eds.).
26. Merritt G. Heroin Moves in to Connecticut Suburbia 2008, Hartford Courant, Hartford.
27. Mueller M.R., Shah N.G., Landen M.G. Unintentional prescription drug overdose deaths in New Mexico, 1994-2003. Am. J. Prev. Med. 2006, 30:423-429.
28. Orcutt J., Turner J. Shocking numbers and graphic accounts: quantified images of drug problems in the print media. Soc. Probl. 1993, 40:190-206.
29. Paulozzi L.J. Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. Am. J. Public Health 2006, 96:1755-1757.
30. Paulozzi L.J., Ballesteros M.F., Stevens J.A. Recent trends in mortality from unintentional injury in the United States. J. Safety Res. 2006, 37:277-283.
31. Paulozzi L.J., Budnitz D.S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol. Drug Saf. 2006, 15:618-627.
32. Paulozzi L.J., Logan J.E., Hall A.J., McKinstry E., Kaplan J.A., Crosby A.E. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 2009, 104:1541-1548.
33. Paulozzi L.J., Ryan G.W. Opioid analgesics and rates of fatal drug poisoning in the United States. Am. J. Prev. Med. 2006, 31:506-511.
34. Paulozzi L.J., Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol. Drug Saf. 2008, 17:997-1005.
35. Piper T.M., Rudenstine S., Stancliff S., Sherman S., Nandi V., Clear A., Galea S. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct. J. 2007, 4:3.
36. Shah N.G., Lathrop S.L., Reichard R.R., Landen M.G. Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction 2008, 103:126-136.
37. Spiller H., Lorenz D.J., Bailey E.J., Dart R.C. Epidemiological trends in abuse and misuse of prescription opioids. J. Addict. Dis. 2009, 28:130-136.
38. Strang J., McCambridge J., Best D., Beswick T., Bearn J., Rees S., Gossop M. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003, 326:959-960.
39. Substance Abuse and Mental Health Services Administration Results From the 2008 National Survey on Drug Use and Health: National Findings. NSDUH Series H-36 2009, Office of Applied Studies, Rockville, MD.
40. U.S. Department of Justice, D.E.A., ARCOS: Automation of Reports and Consolidated Orders System. http://www.deadiversion.usdoj.gov/arcos/index.html.
41. U.S.Government Accountability Office Methadone Associated Overdose Deaths: Factors Contributing to Increased Deaths and Efforts to Prevent Them 2009, Washington, DC.
42. UNODC The World Drug Report 2009, United Nations Office on Drugs and Crime, Vienna, Austria.
43. Wakeman S.E., Bowman S.E., McKenzie M., Jeronimo A., Rich J.D. Preventing death among the recently incarcerated: an argument for naloxone prescription before release. J. Addict. Dis. 2009, 28:124-129.
44. Warner M., Chen L.H., Makuc D.M. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS data brief 2009, National Center for Health Statistics, Hyattsville, MD.
45. Zerzan J.T., Morden N.E., Soumerai S., Ross-Degnan D., Roughead E., Zhang F., Simoni-Wastila L., Sullivan S.D. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med. Care 2006, 44:1005-1010.